Smart contract diffusion in the pharmaceutical blockchain: the battle of counterfeit drugs

Arash Kordestani*, Pejvak Oghazi, Rana Mostaghel

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

13 Citations (Scopus)

Abstract

Counterfeit drugs have long been a major concern. In search of a solution, this study conducted a systematic literature review. Using an automated content analysis of pharmaceutical blockchains, this study identifies the (1) unique characteristics of smart contracts on blockchain platforms in the pharmaceutical supply chain, (2) role of smart contracts to combat counterfeit drugs, and (3) avenues for future studies. Theoretical and managerial implications are discussed at the end of this paper.

Original languageEnglish
Article number113646
Peer-reviewed scientific journalJournal of Business Research
Volume158
ISSN0148-2963
DOIs
Publication statusPublished - 03.2023
MoE publication typeA1 Journal article - refereed

Keywords

  • 512 Business and Management
  • Counterfeit
  • Leximancer
  • Literature review
  • Pharmaceutical blockchain
  • Smart contracts

Fingerprint

Dive into the research topics of 'Smart contract diffusion in the pharmaceutical blockchain: the battle of counterfeit drugs'. Together they form a unique fingerprint.

Cite this